Surmount Laboratories

Mumbai, India Founded: 1983 • Age: 43 yrs
Development, manufacturing, and marketing of pharmaceutical tablets and capsules.

About Surmount Laboratories

Surmount Laboratories is a Healthcare company based in Mumbai (India) founded in 1983. It operates as a development, manufacturing, and marketing of pharmaceutical tablets and capsules. The company has 19 employees. Its Indian entity Surmount Laboratories Limited reported revenue of β‚Ή95.33 Cr. Surmount Laboratories offers products and services including Tablets and Capsules. Its focus areas include Pharmaceuticals, Drug Manufacturing, Finished Dosages and Biotechnology.

Company details

Surmount Laboratories is identified as a global pharmaceutical entity that focuses on the development, manufacturing, and marketing of finished dosages such as tablets and capsules. Efforts are made to ensure access to affordable medicines for patients worldwide, with products tailored to various therapeutic segments. The companys operations are based in India, where cutting-edge technology is utilized to address customer needs in healthcare. Commitment is shown to serving health care requirements across different markets, emphasizing quality and innovation in product offerings.

  • Headquarters Mumbai, India
  • Employees 19
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Legal Name Surmount Laboratories Private Limited
  • Date of Incorporation 28 Mar, 1996
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹95.33 Cr

    FY 2024 · -6% YoY

  • Net Profit
    ₹8.42 Cr

    FY 2024 · 9% margin

  • EBITDA
    ₹13.33 Cr

    FY 2024 · 14% margin

  • Employee Count
    19

Products & Services of Surmount Laboratories

Surmount Laboratories offers a comprehensive portfolio of products and services, including Tablets and Capsules.

Tablets
Pharmaceutical Products

Tablets are developed and manufactured as finished dosages for different therapeutic segments

Capsules
Pharmaceutical Products

Capsules are produced and marketed as finished dosages targeting various therapeutic needs

Board of directors of Surmount Laboratories Limited (Surmount Laboratories)

Surmount Laboratories Limited is the primary company behind Surmount Laboratories. The board of Surmount Laboratories Limited currently have 3 directors; the longest-serving is Minesh Dhirendra Mehta, appointed in 2017. 7 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Minesh Dhirendra Mehta
DIN 08008906
Director04 Dec 20178 yrs 10 moSurmount Laboratories Limited
Dhirendra Maganlal Mehta
DIN 03575117
Director27 Aug 20206 yrs 1 moSurmount Laboratories Limited
Kavit Dhirendrakumar Mehta
DIN 03575128
Director31 Aug 20224 yrs 1 moSurmount Laboratories Limited

Financials of Surmount Laboratories

Figures of Surmount Laboratories Limited, the primary company behind Surmount Laboratories, for FY 2024. Revenue was ₹95.33 Cr (-6% year on year). Net profit was ₹8.42 Cr (9% margin). EBITDA was ₹13.33 Cr (14% margin). Revenue has grown at a compounded annual rate of +6% over three years and +8% over five years.

  • ₹95.33 CrRevenue · FY 2024 · -6% YoY
  • ₹8.42 CrNet profit · 9% margin
  • ₹13.33 CrEBITDA · 14% margin
  • ₹4.72 CrPaid-up capital
  • 19Employees (provident fund records)
  • +6%Revenue CAGR, 3 years
  • +8%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Surmount Laboratories Limited are on its company page.

Premium access

Detailed financial statements for Surmount Laboratories

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

10 companies that operate in the same segment as Surmount Laboratories (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 215.5 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Surmount Laboratories

Surmount Laboratories was founded in 1983.

Surmount Laboratories is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Surmount Laboratories has 19 employees.

The primary company behind Surmount Laboratories, Surmount Laboratories Limited, reported revenue of β‚Ή95.33 Cr for FY 2024, down 6% year on year.

Surmount Laboratories is identified as a global pharmaceutical entity that focuses on the development, manufacturing, and marketing of finished dosages such as tablets and capsules. Efforts are made to ensure access to affordable medicines for patients worldwide, with products tailored to various therapeutic segments. The companys operations are based in India, where cutting-edge technology is utilized to address customer needs in healthcare. Commitment is shown to serving health care requirements across different markets, emphasizing quality and innovation in product offerings.

Surmount Laboratories offers Tablets and Capsules.

Surmount Laboratories operates through Surmount Laboratories Limited.

The legal entities of Surmount Laboratories currently have 3 directors, including Minesh Dhirendra Mehta, Dhirendra Maganlal Mehta, Kavit Dhirendrakumar Mehta.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available